354 related articles for article (PubMed ID: 24128120)
1. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease.
Lv H; Jiang Y; Li J; Zhang M; Shang Z; Zheng J; Wu X; Liu P; Zhang R; Yu H
Mol Biol Rep; 2014 Mar; 41(3):1299-310. PubMed ID: 24407599
[TBL] [Abstract][Full Text] [Related]
3. Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion.
Zammiti W; Mtiraoui N; Cochery-Nouvellon E; Mahjoub T; Almawi WY; Gris JC
Mol Hum Reprod; 2006 Dec; 12(12):771-6. PubMed ID: 17041236
[TBL] [Abstract][Full Text] [Related]
4. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
5. Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.
Zhang H; Ma L; Dong LQ; Shu C; Xu JL
Gene; 2013 Sep; 526(2):228-31. PubMed ID: 23707797
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease.
Ebrahimi Daryani N; Saghazadeh A; Moossavi S; Sadr M; Shahkarami S; Soltani S; Farhadi E; Rezaei N
Immunol Invest; 2017 Oct; 46(7):714-729. PubMed ID: 28872970
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis about the association between -1082G/A and -819C/T polymorphisms of IL-10 gene and risk of type 2 diabetes.
Zhang F; Yang Y; Lei H; Qiu J; Wang Y; Hu D; Skrip L; Chen F
Hum Immunol; 2013 May; 74(5):618-26. PubMed ID: 23376084
[TBL] [Abstract][Full Text] [Related]
8. Predisposition of Inflammatory Bowel Disease Is Influenced by IL-8, IL-10, and IL-18 Polymorphisms: A Meta-Analysis.
Su Y; Zhao H
Int Arch Allergy Immunol; 2020; 181(10):799-806. PubMed ID: 32781445
[TBL] [Abstract][Full Text] [Related]
9. The polymorphisms K469E and G261R of intercellular adhesion molecule-1 and susceptibility to inflammatory bowel disease: a meta-analysis.
Song GG; Lee YH
Immunol Invest; 2015; 44(4):361-72. PubMed ID: 25942347
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 polymorphisms and susceptibility to inflammatory bowel disease: a meta-analysis.
Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG
Hum Immunol; 2014 May; 75(5):414-21. PubMed ID: 24530750
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
[TBL] [Abstract][Full Text] [Related]
12. Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn's Disease: A Meta-Analysis.
Sun M; Zhang L; Shi S
Immunol Invest; 2016; 45(3):255-70. PubMed ID: 27019053
[TBL] [Abstract][Full Text] [Related]
13. Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: a meta-analysis.
Wu H; Guo J; He Y; Yin H; Shu J
Afr Health Sci; 2016 Sep; 16(3):866-872. PubMed ID: 27917223
[TBL] [Abstract][Full Text] [Related]
14. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
15. The Polymorphism rs3024505 (C/T) Downstream of the IL10 Gene Is Associated with Crohn's Disease in Serbian Patients with Inflammatory Bowel Disease.
Mijac D; Petrovic IV; Djuranovic S; Perovic V; Bojic D; Culafic D; Popovic D; Krstic M; Jankovic G; Djoric M; Pravica V; Markovic M
Tohoku J Exp Med; 2016 Sep; 240(1):15-24. PubMed ID: 27558476
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
[TBL] [Abstract][Full Text] [Related]
17. TNF-α, TNF-β and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients.
Al-Mohaya MA; Al-Harthi F; Arfin M; Al-Asmari A
J Appl Oral Sci; 2015; 23(3):295-301. PubMed ID: 26221924
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk.
Liang Y; Xu WD; Zhang M; Qiu LJ; Ni J; Wang XS; Wen PF; Cen H; Leng RX; Pan HF; Ye DQ
Int J Rheum Dis; 2013 Dec; 16(6):616-24. PubMed ID: 24267724
[TBL] [Abstract][Full Text] [Related]
19. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
[TBL] [Abstract][Full Text] [Related]
20. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
